AAAAAA

   
Results: 1-13 |
Results: 13
Embedded processor core with 64-bit architecture and its system-on-chip integration for digital consumer products
Authors: Uchiyama, K Arakawa, F Saito, Y Noguchi, K Hasegawa, A Yoshioka, S Irie, N Kitahara, T Debbage, M Sturges, A
Citation: K. Uchiyama et al., Embedded processor core with 64-bit architecture and its system-on-chip integration for digital consumer products, IEICE TR EL, E84C(2), 2001, pp. 139-149
Targeting of LAK activity to CEA-expressing tumor cells with an anti-CEA scFv/IL-2 fusion protein
Authors: Liao, SX Khare, PD Arakawa, F Kuroki, M Hirose, Y Fujimura, S Tomita, Y Kuroki, M
Citation: Sx. Liao et al., Targeting of LAK activity to CEA-expressing tumor cells with an anti-CEA scFv/IL-2 fusion protein, ANTICANC R, 21(3B), 2001, pp. 1673-1680
Specifically targeted killing of carcinoembryonic antigen (CEA)-expressingcells by a retroviral vector displaying single-chain variable fragmented antibody to CEA and carrying the gene for inducible nitric oxide synthase
Authors: Khare, PD Liao, SX Kuroki, M Hirose, Y Arakawa, F Nakamura, K Tomita, Y Kuroki, M
Citation: Pd. Khare et al., Specifically targeted killing of carcinoembryonic antigen (CEA)-expressingcells by a retroviral vector displaying single-chain variable fragmented antibody to CEA and carrying the gene for inducible nitric oxide synthase, CANCER RES, 61(1), 2001, pp. 370-375
Molecular identification of a human carcinoma-associated glycoprotein antigen recognized by mouse monoclonal antibody FU-MK-1
Authors: Tomita, Y Arakawa, F Yamamoto, T Kuwahara, M Watanabe, R Iwasaki, H Kikuchi, M Kuroki, M
Citation: Y. Tomita et al., Molecular identification of a human carcinoma-associated glycoprotein antigen recognized by mouse monoclonal antibody FU-MK-1, JPN J CANC, 91(2), 2000, pp. 231-238
SH-5: The 64-bit SuperH architecture
Authors: Biswas, P Hasegawa, A Mandaville, S Debbage, K Sturges, A Arakawa, F Saito, Y Uchiyama, K
Citation: P. Biswas et al., SH-5: The 64-bit SuperH architecture, IEEE MICRO, 20(4), 2000, pp. 28-39
Specific targeting strategies of cancer gene therapy using a single-chain variable fragment (scFv) with a high affinity for CEA
Authors: Kuroki, M Arakawa, F Khare, PD Kuroki, M Liao, SX Matsumoto, H Abe, H Imakiire, T
Citation: M. Kuroki et al., Specific targeting strategies of cancer gene therapy using a single-chain variable fragment (scFv) with a high affinity for CEA, ANTICANC R, 20(6A), 2000, pp. 4067-4071
Carcinoma-associated antigens MK-1 and CEA in urological cancers
Authors: Tomita, Y Arakawa, F Hirose, Y Liao, SX Khare, PD Kuroki, M Yamamoto, T Ariyoshi, A Kuroki, M
Citation: Y. Tomita et al., Carcinoma-associated antigens MK-1 and CEA in urological cancers, ANTICANC R, 20(2A), 2000, pp. 793-797
Production and accumulation of thrombospondin-1 in human retinal pigment epithelial cells
Authors: Miyajima-Uchida, H Hayashi, H Beppu, R Kuroki, M Fukami, M Arakawa, F Tomita, Y Kuroki, M Oshima, K
Citation: H. Miyajima-uchida et al., Production and accumulation of thrombospondin-1 in human retinal pigment epithelial cells, INV OPHTH V, 41(2), 2000, pp. 561-567
A 550-ps access 900-MHz 1-Mb ECL-CMOS SRAM
Authors: Nambu, H Kanetani, K Yamasaki, K Higeta, K Usami, M Nishiyama, M Ohhata, K Arakawa, F Kusunoki, T Yamaguchi, K Hotta, A Homma, N
Citation: H. Nambu et al., A 550-ps access 900-MHz 1-Mb ECL-CMOS SRAM, IEEE J SOLI, 35(8), 2000, pp. 1159-1168
Power reduction techniques for a 1-Mb ECL-CMOS SRAM with an access time of550 ps acid an operating frequency of 900 MHz
Authors: Ohhata, K Arakawa, F Kusunoki, T Nambu, H Kanetani, K Yamasaki, K Higeta, K Usami, M Nishiyama, M Yamaguchi, K Homma, N Hotta, A
Citation: K. Ohhata et al., Power reduction techniques for a 1-Mb ECL-CMOS SRAM with an access time of550 ps acid an operating frequency of 900 MHz, IEEE J SOLI, 35(4), 2000, pp. 564-571
Enhanced antitumor activity of a combination treatment with a mouse human chimeric anti-MK-1 antibody and lymphokine-activated killer cells in vitro and in a severe combined immunodeficient mouse xenograft model
Authors: Yamamoto, T Arakawa, F Nakamura, K Senba, T Tomita, Y Ikeda, S Kuroki, M
Citation: T. Yamamoto et al., Enhanced antitumor activity of a combination treatment with a mouse human chimeric anti-MK-1 antibody and lymphokine-activated killer cells in vitro and in a severe combined immunodeficient mouse xenograft model, CANCER IMMU, 48(4), 1999, pp. 165-171
cDNA sequence analysis of monoclonal antibody FU-MK-1 specific for a transmembrane carcinoma-associated antigen, and construction of a mouse human chimeric antibody
Authors: Arakawa, F Yamamoto, T Kanda, H Watanabe, T Kuroki, M
Citation: F. Arakawa et al., cDNA sequence analysis of monoclonal antibody FU-MK-1 specific for a transmembrane carcinoma-associated antigen, and construction of a mouse human chimeric antibody, HYBRIDOMA, 18(2), 1999, pp. 131-138
Chimeric MAb ch FU-MK-1
Authors: Arakawa, F Kuroki, M
Citation: F. Arakawa et M. Kuroki, Chimeric MAb ch FU-MK-1, HYBRIDOMA, 18(2), 1999, pp. 216-216
Risultati: 1-13 |